{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T17:20:30Z","timestamp":1780852830415,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,2,17]],"date-time":"2003-02-17T00:00:00Z","timestamp":1045440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2003,2,17]],"date-time":"2003-02-17T00:00:00Z","timestamp":1045440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Inorganic mercury poisoning is uncommon, but when it occurs it can result in severe, life-threatening features and acute renal failure. Previous reports on the use of extracorporeal procedures such as haemodialysis and haemoperfusion have shown no significant removal of mercury. We report here the successful use of the chelating agent 2,3-dimercaptopropane-1-sulphonate (DMPS), together with continuous veno-venous haemodiafiltration (CVVHDF), in a patient with severe inorganic mercury poisoning.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Case report<\/jats:title>\n                        <jats:p>A 40-year-old man presented with haematemesis after ingestion of 1 g mercuric sulphate and rapidly deteriorated in the emergency department, requiring intubation and ventilation. His initial blood mercury was 15 580 \u03bcg\/l. At 4.5 hours after ingestion he was started on DMPS. He rapidly developed acute renal failure and so he was started on CVVHDF for renal support and in an attempt to improve mercury clearance; CVVHDF was continued for 14 days.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Regular ultradialysate and pre- and post-filtrate blood samples were taken and in addition all ultradialysate generated was collected to determine its mercury content.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>The total amount of mercury in the ultrafiltrate was 127 mg (12.7% of the ingested dose). The sieving coefficient ranged from 0.13 at 30-hours to 0.02 at 210-hours after ingestion. He developed no neurological features and was discharged from hospital on day 50. Five months after discharge from hospital he remained asymptomatic, with normal creatinine clearance.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Discussion<\/jats:title>\n                        <jats:p>We describe a patient with severe inorganic mercury poisoning in whom full recovery occurred with the early use of the chelating agent DMPS and CVVHDF. There was removal of a significant amount of mercury by CVVHDF.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>We feel that CVVHDF should be considered in patients with inorganic mercury poisoning, particularly those who develop acute renal failure, together with meticulous supportive care and adequate doses of chelation therapy with DMPS.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc1887","type":"journal-article","created":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T12:27:54Z","timestamp":1051792074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Case report: Severe mercuric sulphate poisoning treated with 2,3-dimercaptopropane-1-sulphonate and haemodiafiltration"],"prefix":"10.1186","volume":"7","author":[{"given":"Paul I","family":"Dargan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy J","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig I","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan M","family":"House","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison H","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Beale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,2,17]]},"reference":[{"key":"1929_CR1","first-page":"262","volume-title":"In Clinical Toxicology of Commercial Products","author":"RE Gosselin","year":"1984","unstructured":"Gosselin RE, Smith RE, Hodge HC: Mercury.\n                           In Clinical Toxicology of Commercial Products\n                           5 Edition\n                           (Edited by: Gosselin RE, Smith RE, Hodge HC). Baltimore: Williams and Wilkins 1984, 262-275.","edition":"5"},{"key":"1929_CR2","first-page":"129","volume":"3","author":"KA Winship","year":"1985","unstructured":"Winship KA: Toxicity of mercury and its inorganic salts.\n                           Adv Drug React Ac Pois Rev 1985, 3: 129-160.","journal-title":"Adv Drug React Ac Pois Rev"},{"key":"1929_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF00333982","volume":"35","author":"B Gabard","year":"1976","unstructured":"Gabard B: The excretion and distribution of inorganic mercury in the rat as influenced by several chelating agents.\n                           Arch Toxicol 1976, 35: 15-24.","journal-title":"Arch Toxicol"},{"key":"1929_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF03259951","volume":"2","author":"K Hruby","year":"1987","unstructured":"Hruby K, Donner A: 2,3-dimercapto-1-propanesulphonate in heavy metal poisoning.\n                           Med Toxicol 1987, 2: 317-323.","journal-title":"Med Toxicol"},{"key":"1929_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/15563658108990034","volume":"18","author":"CL Wineck","year":"1981","unstructured":"Wineck CL: Fatal mercuric chloride poisoning.\n                           J Toxicol Clin Toxicol 1981, 18: 261-266.","journal-title":"J Toxicol Clin Toxicol"},{"key":"1929_CR6","first-page":"662","volume":"268","author":"KM Hurlbut","year":"1994","unstructured":"Hurlbut KM, Maiorino RM, Mayersohn M, Dart RC, Bruce DC, Aposhian HV: Determination and metabolism of dithiol chelating agents. XVI: pharmacokinetics of 2,3-dimercapto-1-propanesulphonate after intravenous administration to human volunteers.\n                           J Pharmacol Exp Ther 1994, 268: 662-668.","journal-title":"J Pharmacol Exp Ther"},{"key":"1929_CR7","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/pgmj.60.707.636","volume":"60","author":"DP Worth","year":"1984","unstructured":"Worth DP, Davison AM, Lewins AM, Ledgerwood MJ, Taylor A: Haemodialysis and charcoal haemoperfusion in acute inorganic mercury poisoning.\n                           Postgrad Med J 1984, 60: 636-638.","journal-title":"Postgrad Med J"},{"key":"1929_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/096032719000900303","volume":"9","author":"PJ Kostyniak","year":"1990","unstructured":"Kostyniak PJ, Greizerstein HB, Goldstein J, Lachaal M, Reddy P, Clarkson TW, Walshe J, Cunningham E: Extracorporeal regional complexing hemodialysis treatment of acute inorganic mercury intoxication.\n                           Hum Exp Toxicol 1990, 9: 137-141.","journal-title":"Hum Exp Toxicol"},{"key":"1929_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/jat\/6.3.120","volume":"6","author":"ER Samuels","year":"1982","unstructured":"Samuels ER, Heick HMC, McLaine P, Farant JP: A case of inorganic mercury poisoning.\n                           J Anal Toxicol 1982, 6: 120-122.","journal-title":"J Anal Toxicol"},{"key":"1929_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/15563657708989844","volume":"11","author":"EP Leumann","year":"1977","unstructured":"Leumann EP, Brandernberger H: Hemodialysis in a patient with acute mercuric cyanide intoxication. Concentrations of mercury in blood, dialysate, urine, vomitus and faeces.\n                           J Toxicol Clin Toxicol 1977, 11: 301-308.","journal-title":"J Toxicol Clin Toxicol"},{"key":"1929_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/096032718300200310","volume":"3","author":"JA Newton","year":"1983","unstructured":"Newton JA, House IM, Volans GN, Goodwin FJ: Plasma mercury during prolonged acute renal failure after mercuric chloride ingestion.\n                           Hum Exp Toxicol 1983, 3: 535-537.","journal-title":"Hum Exp Toxicol"},{"key":"1929_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/15563658308990064","volume":"20","author":"TJ Pelline","year":"1983","unstructured":"Pelline TJ, Karjalainen K, Haapanen EJ: Haemoperfusion in mercury poisoning.\n                           J Toxicol Clin Toxicol 1983, 20: 187-189.","journal-title":"J Toxicol Clin Toxicol"},{"key":"1929_CR13","first-page":"451","volume":"46","author":"M Nordberg","year":"2000","unstructured":"Nordberg M, Nordberg GM: Toxicological aspects of metallothionein.\n                           Cell Mol Biol 2000, 46: 451-463.","journal-title":"Cell Mol Biol"},{"key":"1929_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/096032719401300103","volume":"13","author":"AE Toet","year":"1994","unstructured":"Toet AE, van Dijk A, Savelkoul TJF, Meulenbelt J: Mercury kinetics in a case of severe mercuric chloride poisoning treated with dimercapto-1-propanesulphonate (DMPS).\n                           Hum Exp Toxicol 1994, 13: 11-16.","journal-title":"Hum Exp Toxicol"},{"key":"1929_CR15","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1001\/jama.1986.03380220093029","volume":"256","author":"JR Campbell","year":"1986","unstructured":"Campbell JR, Clarkson TW, Omar MD: The therapeutic use of 2,3-dimercaptopropane-1-sulphonate in two cases of inorganic mercury poisoning.\n                           JAMA 1986, 256: 3127-3130. 10.1001\/jama.256.22.3127","journal-title":"JAMA"},{"key":"1929_CR16","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/000992287701601015","volume":"16","author":"A Kahn","year":"1977","unstructured":"Kahn A, Denis R, Blum D: Accidental ingestion of mercuric sulphate in a 4 year old child.\n                           Clin Pediatr 1977, 16: 956-958.","journal-title":"Clin Pediatr"},{"key":"1929_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/archinte.1974.00320190141023","volume":"134","author":"DT Lowenthal","year":"1974","unstructured":"Lowenthal DT, Chardo F, Reidenberg MM: Removal of mercury by peritoneal dialysis.\n                           Arch Intern Med 1974, 134: 139-141. 10.1001\/archinte.134.1.139","journal-title":"Arch Intern Med"},{"key":"1929_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/BF01721058","volume":"59","author":"F Keller","year":"1981","unstructured":"Keller F, Koeppel C, von Keyserling HJ, Schultze G: Haemoperfusion for organic mercury detoxication?\n                           Klin Wochenschr 1981, 59: 865-866.","journal-title":"Klin Wochenschr"},{"key":"1929_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1365-2044.1991.tb09351.x","volume":"46","author":"GA McLauchlan","year":"1991","unstructured":"McLauchlan GA: Acute mercury poisoning.\n                           Anaesthesia 1991, 46: 110-112.","journal-title":"Anaesthesia"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc1887.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc1887\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc1887.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:57:35Z","timestamp":1728305855000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc1887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,17]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2003,6]]}},"alternative-id":["1929"],"URL":"https:\/\/doi.org\/10.1186\/cc1887","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,17]]},"assertion":[{"value":"29 October 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2003","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2003","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2003","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R1"}}